Evaluating the therapeutic effect of ursodeoxycholic acid on the reduction of serum bilirubin in neonates with prolonged jaundice
Phase 3
Recruiting
- Conditions
- eonatal jaundice.Neonatal jaundice from other and unspecified causes
- Registration Number
- IRCT20180228038895N2
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
Serum bilirubin above 10 mg/dl
Indirect hyperbilirubinemia (below 1)
Exclusion Criteria
Conjugated hyperbilirubinemia (direct bilirubin above 1)
Disruption of TSH and T4
Clinical evidence of infection
Urinary tract infection
Sick neonates
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total and direct serum bilirubin. Timepoint: On the day of visit and 5 days after the intervention. Method of measurement: Measurement of serum bilirubin level in serum sample in laboratory with kit.
- Secondary Outcome Measures
Name Time Method